Randox have identified a cardiac marker which has a prognostic value. Elevated H-FABP is a significant predictor of death or MI within 1 year H-FABP provides additional prognostic information independent of Troponin T, ECG and clinical examination Increased H-FABP concentrations confers increased risk "Patients with H-FABP concentrations >6.48 µg/L had significantly increased risk of adverse events" "Among Troponin negative patients, the cut-off of 6.48 µg/L identified patients at very high risk of adverse outcomes independent of patient age and serum Creatinine"